Roche Holding AG (RHHBY)
48.52
+0.32
(+0.66%)
USD |
OTCM |
Dec 05, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 309.10B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 38.05% |
| Valuation | |
| PE Ratio | 28.56 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 4.385 |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 1.389 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -- |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 40.92% |
Profile
| Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. |
| URL | http://www.roche.com |
| Investor Relations URL | https://www.roche.com/investors.htm |
| HQ State/Province | Basel-Stadt (Basle Town) |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jan. 29, 2026 |
| Last Earnings Release | Jul. 24, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 28, 2025 |
Ratings
Profile
| Roche Holding AG is a research healthcare company. It operates through the Roche Pharmaceuticals and Diagnostics segments. The Roche Pharmaceutical division comprises the business segments, such as Roche Pharmaceuticals and Chuga. The Diagnostic division consists of the following four business areas: centralized and point of care solutions, molecular diagnostics, tissue diagnostics, and diabetes care. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. |
| URL | http://www.roche.com |
| Investor Relations URL | https://www.roche.com/investors.htm |
| HQ State/Province | Basel-Stadt (Basle Town) |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Next Earnings Release | Jan. 29, 2026 |
| Last Earnings Release | Jul. 24, 2025 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Mar. 28, 2025 |